News Center

NEWS CENTER

The company has mastered a number of leading core technologies and patented technologies in the field of pharmaceutical research and development and cosmetics.


Release time:

2021-02-23

The company has leading advantages in technology patents, standard formulation, innovative development and R & D team. Compared with the disadvantages of single chemical product technology limitation, serious environmental pollution and high energy consumption in the same industry, we focus on making major breakthroughs in green chemistry, energy conservation and environmental protection, product quality, high-tech, technical solutions and technical documents supporting products, in order to meet the United States, the European Union and other developed countries related industry products, environmental and technical requirements.

Our products are mainly exported to India, Japan, Korea, Eastern Europe, North America, South America and the Middle East. We have a professional foreign trade marketing team, with high-quality service, reliable quality, stable production and supply, has been well received and widely recognized by customers, and has established a long-term cooperative relationship with it. We will further expand the domestic and foreign markets, continuously improve the comprehensive level of R & D and production, and establish a world-class intermediate and API manufacturing enterprise.

Beijing Tianhong Tianda Pharmaceutical Technology Co., Ltd. is a high-tech enterprise and Beijing high-tech enterprise integrating R & D, production and sales of pharmaceutical and cosmetic raw materials. At present, our company has won many domestic and international independent intellectual property rights, and has been rated as Beijing patent pilot unit by Beijing Daxing District Intellectual Property Office.

The company's headquarters and R & D center is located in Beijing Zhongguancun Science Park Daxing biomedical industry base, convenient transportation, beautiful environment. The R & D center covers an area of about 1500 square meters, with synthesis room, analysis room, pilot plant, quality inspection center and other departments. The company has a number of independent intellectual property rights, and has a rigorous, realistic, innovative, dedicated research team, they have skilled organic synthesis technology and rich production experience, good at new product research and development, pilot, industrial production, and the optimization and improvement of existing production processes, to maximize customer demand for new products.

Recommended News

STATEMENT

2025-07-09

STATEMENT

2025-07-09

In the first half of the year, 15 major international beauty giants sold 520 billion

On the evening of August 18, Estee Lauder released financial results for fiscal year 2022 Q4 and fiscal year 2022. Data show that in fiscal year 2022, Estee Lauder achieved net sales of US $17.74 billion (approximately RMB 120.35 billion), a year-on-year increase of 9%; but net profit was US $2.39 billion (approximately RMB 16.217 billion), a year-on-year decrease of 16%.

2022-08-26